- Home
- MIRA vs UMAC Comparison
MIRA vs UMAC Comparison
Compare MIRA & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- UMAC
- Stock Information
- Founded
- MIRA 2020
- UMAC 2019
- Country
- MIRA United States
- UMAC United States
- Employees
- MIRA N/A
- UMAC N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- UMAC
- Sector
- MIRA Health Care
- UMAC
- Exchange
- MIRA Nasdaq
- UMAC Nasdaq
- Market Cap
- MIRA 17.1M
- UMAC 20.4M
- IPO Year
- MIRA 2023
- UMAC 2024
- Fundamental
- Price
- MIRA $1.47
- UMAC $3.22
- Analyst Decision
- MIRA Strong Buy
- UMAC Strong Buy
- Analyst Count
- MIRA 2
- UMAC 1
- Target Price
- MIRA $14.00
- UMAC $4.00
- AVG Volume (30 Days)
- MIRA 3.6M
- UMAC 126.4K
- Earning Date
- MIRA 11-12-2024
- UMAC 11-14-2024
- Dividend Yield
- MIRA N/A
- UMAC N/A
- EPS Growth
- MIRA N/A
- UMAC N/A
- EPS
- MIRA N/A
- UMAC N/A
- Revenue
- MIRA N/A
- UMAC $2,030,039.00
- Revenue This Year
- MIRA N/A
- UMAC N/A
- Revenue Next Year
- MIRA N/A
- UMAC $66.18
- P/E Ratio
- MIRA N/A
- UMAC N/A
- Revenue Growth
- MIRA N/A
- UMAC N/A
- 52 Week Low
- MIRA $0.51
- UMAC $0.98
- 52 Week High
- MIRA $6.40
- UMAC $5.54
- Technical
- Relative Strength Index (RSI)
- MIRA 48.43
- UMAC 75.40
- Support Level
- MIRA $1.65
- UMAC $2.45
- Resistance Level
- MIRA $1.75
- UMAC $3.53
- Average True Range (ATR)
- MIRA 0.33
- UMAC 0.44
- MACD
- MIRA -0.03
- UMAC 0.15
- Stochastic Oscillator
- MIRA 13.01
- UMAC 85.24
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is a development stage technology company.